This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Study Finds Upsurge in ‘Active Surveillance’ ... Many men with low-risk prostate cancer who most likely ... (12 Feb 2019)
German Researchers Discover How Sleep Can ... Researchers in Germany have discovered why sleep can sometimes ... (12 Feb 2019)
Oral contraceptives could impair women's ... Healthy women who use birth control pills are poorer judges of ... (12 Feb 2019)
With Age Comes Hearing Loss and a Greater ... But study suggests higher education might counter effects of ... (12 Feb 2019)
Better chocolate choices benefit heart health For Valentine’s Day consideration, skip the milk chocolate candy ... (12 Feb 2019)
Tuesday, 20 November 2018 07:39

Compound Derived from Marijuana May Benefit Children with Epilepsy Featured

Rate this item
(0 votes)

In recent years, cannabinoids—the active chemicals inmedicalmarijuana— have been increasingly touted as a potential treatment for a range of neurological and psychiatric disorders. In a Developmental Medicine & Child Neurology review, investigators compare their efficacy with antiepileptic drugs for children with epilepsy.


One cannabinoid, called cannabidiol (CBD), has the most evidence of antiepileptic efficacy and does not have psychoactive effects. There has been little evidence for its use apart from anecdotal reports, until the last year.

The review notes that in three randomized, placebo-controlled, double-blind trials in Dravet syndrome and Lennox–Gastaut syndrome (two forms of childhood epilepsy), CBD produced a 38 percent to 41 percent median reduction in all seizures compared with 13 percent to 19 percent with placebo. Similarly, CBD resulted in a 39 percent to 46 percent responder rate (50 percent convulsive or drop-seizure reduction) compared with 14 percent to 27 percent with placebo. CBD was well tolerated, however sedation, diarrhoea, and decreased appetite were frequent.

“Community debate about the use of CBD and access to this antiepileptic therapy has been heated,” the authors wrote. “With further trials and greater understanding of its role, the place of CBD in our antiepileptic armamentarium and its impact on comorbidities will become clearer.”



Source: Wiley
Full bibliographic information

Efficacy of cannabinoids in paediatric epilepsy. Dev Med Child Neurol.

 

Read 239 times

Latest news

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…